过去 90 天内没有内部人买入。最近一笔由 Hatchett Steven Keith 披露于 2025年11月12日。
NU Skin Enterprises, Inc.:高管交易动态
NU Skin Enterprises, Inc.属于医疗与制药行业,创立于1984年。其高管的申报经由SEC (Form 4)发布。截至2026年10月24日的十二个月内,共提交33份申报,来自9位高管。
资金流向单一:1位高管买入(1笔买入,合计€4.6万),无人在市场上卖出。公开市场买入要按现价、用自有资金支付,这一点有别于作为薪酬获得的股份。2025年11月12日由Hatchett Steven Keith公布的买入金额为€4.6万,是期内最大的一笔。在买入一方,申报人包括1位高级管理人员。
最近一次买入已有一段时间:它于2025年11月12日公布,距今361天。一般而言,一笔交易从发生到公布的中位间隔为2天。第16条规则给予每份Form 4表格两个工作日的提交时间。
与所在交易所相比(2,023家公司,中位数41份申报),33份申报的数量低于常态。我们关于NU Skin Enterprises, Inc.的记录可追溯至2006年,累计有57笔买入和448笔卖出。基本面方面,截至2025年12月31日财年的美国证监会文件(10-K)列出营收14.85亿 USD、净利润1.60亿 USD。
这些数据整理自监管申报(来源:SEC (Form 4)),仅描述高管的操作,并非投资推荐。
谁在何时交易
买入卖出内部人买入以来
- -49.7%入场价 US$9.78 · 2026年10月22日 收盘 US$4.92
- -1.6%入场价 US$49.56 · T+365 收盘 US$48.76
- +4.1%入场价 US$49.59 · T+365 收盘 US$51.63
入场价为披露次日收盘价,即读者可操作的第一个价格。价格以上市货币计。过往涨跌不代表未来表现。
该评分只在所属市场内对买入进行排名。仅在经过回测的策略范围内的交易所提供建议仓位;其他市场的信号仍处于观察状态。并非投资建议。
透明的价值 + 质量排名,独立于内部人交易信号。
财务数据
财年 2025财年截至 2025年12月 · cache
- 22 股@ US$4.850.0000% 占市值0.0% 占其流量股票SEC:0001021561-26-000065:0
- 26,643 股0股票SEC:0001021561-26-000057:0
- 26,643 股0股票SEC:0001021561-26-000055:0
- 7,203 股@ US$5.620.016% 占市值100.0% 占其流量Class ASEC144:0001959173-26-004237
- 14 股@ US$7.310.1% 占其流量股票SEC:0001021561-26-000042:0
- 47,059 股0股票SEC:0001021561-26-000040:0
- 138,971 股0股票SEC:0001021561-26-000036:0
- 77,941 股0股票SEC:0001021561-26-000038:0
- 114,706 股0股票SEC:0001021561-26-000034:0
- 282,353 股0股票SEC:0001021561-26-000032:0
- 13,687 股@ US$8.6366.1% 占其流量股票SEC:0001021561-26-000030:0
- 45,502 股@ US$8.6325.3% 占其流量股票SEC:0001021561-26-000026:0
- 124,802 股@ US$8.6321.6% 占其流量股票SEC:0001021561-26-000022:0
- 28,602 股@ US$8.6325.1% 占其流量股票SEC:0001021561-26-000024:0
- 26,001 股@ US$8.6313.0% 占其流量股票SEC:0001021561-26-000028:0
- 11,725 股@ US$8.369.9% 占其流量股票SEC:0001021561-26-000014:0
- 1,534 股@ US$8.367.1% 占其流量股票SEC:0001021561-26-000020:0
- 10,763 股@ US$8.365.2% 占其流量股票SEC:0001021561-26-000018:0
- 17,947 股@ US$8.369.6% 占其流量股票SEC:0001021561-26-000016:0
- 49,037 股@ US$8.368.2% 占其流量股票SEC:0001021561-26-000012:0
- 75,466 股0股票SEC:0001021561-26-000006:1
- 206,988 股0股票SEC:0001021561-26-000002:1
- 34,500 股0股票SEC:0001021561-26-000010:1
- 43,124 股0股票SEC:0001021561-26-000008:1
- 47,436 股0股票SEC:0001021561-26-000004:1
1538 条申报中的 25 条
About NU Skin Enterprises, Inc.
Nu Skin Enterprises, Inc. (NYSE: NUS) is a U.S.-listed company on the New York Stock Exchange, headquartered in Provo, Utah, United States. Founded in 1984, the company grew out of a direct-selling model and has evolved into a global beauty and wellness platform that combines consumer brands, product innovation, and an affiliate-based distribution network. For investors, Nu Skin should be viewed as a specialized consumer-health and prestige-beauty franchise with exposure to anti-aging, preventive wellness, and social/digital commerce trends. ([nuskin.com](https://www.nuskin.com/in/en/site/company/about-us?utm_source=openai))\n\nThe business is organized around two principal product categories: beauty and wellness. Under the Nu Skin brand, the company sells skincare, personal care, and beauty device systems. Under Pharmanex, it offers nutritional supplements and wellness-oriented products. The ageLOC franchise is a core differentiator, spanning anti-aging skincare, connected beauty devices, and products positioned around healthy aging. Nu Skin emphasizes more than 40 years of scientific research, clinical substantiation, and innovation as part of its premium brand positioning and distributor appeal. ([ir.nuskin.com](https://ir.nuskin.com/news-releases/news-release-details/nu-skin-enterprises-announce-fourth-quarter-and-full-year-2025?utm_source=openai))\n\nNu Skin operates in nearly 50 markets worldwide, giving it a broad geographic footprint across Asia-Pacific, the Americas, Europe, and other international regions. That global reach supports revenue diversification and brand visibility, but it also introduces foreign-exchange volatility, local regulatory complexity, and uneven consumer demand across regions. In 2025, revenue was primarily generated by the beauty and wellness categories, while the Rhyz ecosystem contributed additional income through adjacent consumer, technology, and manufacturing activities. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1021561/000114036126013156/ef20069502_ars.pdf?utm_source=openai))\n\nFrom a competitive standpoint, Nu Skin operates in a crowded landscape that includes multinational cosmetics groups, direct-selling peers, and digitally native consumer brands. Its competitive advantages lie in its long operating history, international affiliate base, premium product portfolio, and recurring product-launch cadence. Recent company disclosures show that fiscal 2025 results came in within guidance, and the company’s initial fiscal 2026 outlook points to a return to revenue growth by year-end. Recent notable initiatives include the launch of Prysm iO and continued expansion of ageLOC lines, signaling an ongoing effort to reignite organic growth and strengthen customer and affiliate retention. ([ir.nuskin.com](https://ir.nuskin.com/news-releases/news-release-details/nu-skin-enterprises-reports-fourth-quarter-and-full-year-2025?utm_source=openai))
